Results 11 to 20 of about 4,041 (175)

Profiling of intracellular metabolites produced from galactose and its potential for galactosemia research

open access: yesOrphanet Journal of Rare Diseases, 2018
Background Clinical outcome of patients with a classical presentation of galactosemia (classical patients) varies substantially, even between patients with the same genotype.
Michel van Weeghel   +5 more
doaj   +2 more sources

Human Hepatic Uridine Diphosphate Galactose Pyrophosphorylase

open access: yesJournal of Biological Chemistry, 1969
H D Abraham, R R Howell
openaire   +2 more sources

Multienzyme Platform for the Synthesis of UDP Sugars and Human Milk Oligosaccharides. [PDF]

open access: yesChembiochem
Engineered Escherichia coli produces six enzymes (UMPK, PPK3, GALK, NAHK, GALU, PPA) that are purified and used in a cell‐free cascade to synthesize UDP‐N‐acetylglucosamine (UDP‐GlcNAc) and UDP‐galactose (UDP‐Gal) from inexpensive substrates. The cascades can be coupled with glycosyltransferases for in situ nucleotide sugar regeneration, enabling ...
Hoang TS   +6 more
europepmc   +2 more sources

Liver Metabolomic Profiling Reveals Distinct Signatures Between Steatosis and Metabolic Dysfunction-Associated Steatohepatitis. [PDF]

open access: yesLiver Int
ABSTRACT Background and Aims Metabolic dysfunction‐associated steatotic liver disease (MASLD), the most common chronic liver disease worldwide, is closely linked to obesity and metabolic syndrome. The reason some patients with MASLD develop metabolic dysfunction‐associated steatohepatitis (MASH) and which metabolic changes in the liver are linked to ...
Palomurto S   +14 more
europepmc   +2 more sources

A Synergistic Inhibitor Development Strategy Against Human UDP-Galactose-4-Epimerase. [PDF]

open access: yesAngew Chem Int Ed Engl
The epimerase GalE is crucial for the biosynthesis of cancer‐relevant O‐GalNAc glycans. Here, we employ orthogonal, structurally enabled small molecule fragment screens to yield both covalent and non‐covalent inhibitors against GalE within no more than 22 elaborated compounds.
Browne WM   +22 more
europepmc   +2 more sources

Computer-aided identification of Trypanosoma brucei uridine diphosphate galactose 4'-epimerase inhibitors: toward the development of novel therapies for African sleeping sickness. [PDF]

open access: yesJ Med Chem, 2010
Trypanosoma brucei, the causative agent of human African trypanosomiasis, affects tens of thousands of sub-Saharan Africans. As current therapeutics are inadequate due to toxic side effects, drug resistance, and limited effectiveness, novel therapies are
Durrant JD   +3 more
europepmc   +2 more sources

Mass Spectrometry Imaging-Assisted Discovery of Gallotannin Biosynthetic Genes in the Root of Paeonia suffruticosa. [PDF]

open access: yesAdv Sci (Weinh)
An integrated approach combining mass spectrometry imaging, transcriptomics, and phylogenetic analysis facilitated the efficient identification of genes involved in gallotannin biosynthesis in Paeonia suffruticosa. As a result, a key UGT and several SCPL acyltransferases responsible for biosynthesizing pentagalloylglucose were successfully identified ...
Liu Y, Duan W, Tang W, Zhao Y, Li B.
europepmc   +2 more sources

Zoledronate Derivatives as Potential Inhibitors of Uridine Diphosphate-Galactose Ceramide Galactosyltransferase 8:A Combined Molecular Docking and Dynamic Study [PDF]

open access: yes, 2016
Krabbe's disease is a neurodegenerative disorder caused by deficiency of galactocerebrosidase activity that affects the myelin sheath of the nervous system, involving dysfunctional metabolism of sphingolipids. It has no cure. Because substrate inhibition
Cardile, Venera   +5 more
core   +1 more source

Ganglioside biosynthesis. Characterization of uridine diphosphate galactose: GM2 galactosyltransferase in Golgiapparatus from rat liver

open access: yesJournal of Lipid Research, 1976
An enzyme that transfers galactose from UDP-Gal to ganglioside GM2 (Tay-Sachs ganglioside) was concentrated 50 times in Golgi apparatus from rat liver relative to total homogenates.
F E Wilkinson, D J Morré, T W Keenan
doaj   +1 more source

Urinary reducing substances in neonatal intrahepatic cholestasis caused by citrin deficiency

open access: yesJournal of Pediatric and Neonatal Individualized Medicine, 2014
Neonatal cholestasis due to citrin deficiency is an autosomal recessive metabolic disorder caused by mutations in SLC25A13 gene. Mutations in this gene have a relatively high prevalence in East-Asian races compared to European or Afro-Caribbean races ...
Ajmal Kader   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy